Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriele Stefanzl
Observed names:
G Stefanzl,
G. Stefanzl,
Stefanzl, Gabriele
Institutions:
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
Observed institutions:
University of Vienna,
Ludwig Boltzmann Institute for Hematology and Oncology,
Medical University of Vienna
ORCID:
0000-0002-6759-4662
Observed ORCID:
0000-0002-6759-4662
OpenAlex ID:
A5001718541
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
2014
·
Harald Herrmann
, Irina Sadovnik
, et al.
·
Blood
·
234
PDF
Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
2020
·
Harald Herrmann
, Irina Sadovnik
, et al.
·
Blood Advances
·
114
PDF
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
2015
·
Irina Sadovnik
, Andrea Hoelbl-Kovacic
, et al.
·
Clinical Cancer Research
·
75
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
2015
·
B Peter
, G E Winter
, et al.
·
Leukemia
·
65
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia
2014
·
Sabine Cerny-Reiterer
, Anja Rabenhorst
, et al.
·
Oncotarget
·
63
PDF
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis
2015
·
Katharina Blatt
, Sabine Cerny-Reiterer
, et al.
·
Blood
·
62
BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
2017
·
D. Smiljkovic
, K. Blatt
, et al.
·
Allergy
·
59
PDF
Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA
2014
·
Irina Sadovnik
, Els Lierman
, et al.
·
Experimental Hematology
·
44
PDF
Phenotyping and Target Expression Profiling of CD34+/CD38− and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
2018
·
Katharina Blatt
, Ingeborg Menzl
, et al.
·
Neoplasia
·
42
PDF
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.
2021
·
Karoline V Gleixner
, Yüksel Filik
, et al.
·
American Journal of Cancer Research
·
41
Expression of sulfotransferases and sulfatases in human breast cancer: Impact on resveratrol metabolism
2009
·
Michaela Miksits
, Katrin Wlcek
, et al.
·
Cancer Letters
·
39
The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells
2013
·
Barbara Peter
, Sabine Cerny-Reiterer
, et al.
·
Journal of Leukocyte Biology
·
38
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
2018
·
Mathias Schneeweiss
, Barbara Peter
, et al.
·
Haematologica
·
37
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils
2022
·
Dubravka Smiljkovic
, Harald Herrmann
, et al.
·
Journal of Allergy and Clinical Immunology
·
30
PDF
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia
2022
·
Barbara Peter
, Gregor Eisenwort
, et al.
·
American Journal of Hematology
·
28
PDF
Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia
2017
·
Michael Willmann
, Irina Sadovnik
, et al.
·
Experimental Hematology
·
28
Identification of a leukemia-initiating stem cell in human mast cell leukemia
2019
·
Gregor Eisenwort
, Irina Sadovnik
, et al.
·
Leukemia
·
27
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
2017
·
B Peter
, S Bibi
, et al.
·
Leukemia
·
26
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis
2018
·
Niklas Mueller
, Daniel Wicklein
, et al.
·
Blood
·
25
PDF
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML
2019
·
Mathias Schneeweiss-Gleixner
, Konstantin Byrgazov
, et al.
·
EBioMedicine
·
21
PDF
Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
2014
·
Sabine Cerny-Reiterer
, Renata A. Meyer
, et al.
·
Oncotarget
·
21
PDF
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia
2021
·
Gregor Eisenwort
, Irina Sadovnik
, et al.
·
Leukemia
·
20
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation
2016
·
Angélica Cuapio
, Mirte Post
, et al.
·
Oncotarget
·
20
PDF
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
2019
·
Susanne Gamperl
, Gabriele Stefanzl
, et al.
·
Veterinary and Comparative Oncology
·
18
PDF
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
2023
·
Lina Degenfeld-Schonburg
, Susanne Gamperl
, et al.
·
PubMed Central
·
16
PDF
Show more works
View as search
Works count:
59
Citation count:
1,305
H-index:
21
I10-index:
28
Year
Topic
Type